Bharat Bhushan Sharma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bharat Bhushan Sharma has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Virendra Singh
Director, Asthma Bhawan, Jaipur, Rajasthan, India
8 shared publications- Aloke Gopal Ghoshal
National Allergy Asthma Bronchitis Institute, Kolkata, India
1 shared publication - Arpita Jindal
Department of Pathology, Swai Maan Singh Medical College and Attached Hospital, Jaipur, Rajasthan
1 shared publication - Bhavin Jankharia
Picture This By Jankharia, Mumbai, India
1 shared publication - Bridget F. Collins
Department of Medicine, Center for Interstitial Lung Diseases, University of Washington Medical Center, 1959 NE Pacific Street, Box 356166, Seattle, WA 98195-6166, USA
1 shared publication - Daya K. Mangal
29 Department of Research, IIHMR University, Jaipur, India
1 shared publication
Latest Publications
- Open Access
- 1 January 2020
- Published by Medknow in Lung India
- Vol. 37 (3) , 268-271
Severe acute respiratory syndrome-coronavirus 2 and novel coronavirus disease 2019: An extraordinary pandemic
COVID-19 has emerged as one of the most significant illnesses of the current century. It is caused by severe acute respiratory syndrome coronavirus 2. The world was initially viewing it as a localized outbreak in Wuhan city of China; however, it started spreading quickly to other parts of the world. Globally, half-hearted containment measures and a false sense of safety against this novel coronavirus led to the dissemination of disease. Currently, no effective therapy or vaccine is available to manage this illness. After learning a huge lesson, global efforts would hopefully lead to effective control of this pandemic.
- 1 January 2020
- Published by Medknow in Lung India
- Vol. 37 (3) , 268-271
Open AccessSevere acute respiratory syndrome-coronavirus 2 and novel coronavirus disease 2019: An extraordinary pandemic
COVID-19 has emerged as one of the most significant illnesses of the current century. It is caused by severe acute respiratory syndrome coronavirus 2. The world was initially viewing it as a localized outbreak in Wuhan city of China; however, it started spreading quickly to other parts of the world. Globally, half-hearted containment measures and a false sense of safety against this novel coronavirus led to the dissemination of disease. Currently, no effective therapy or vaccine is available to manage this illness. After learning a huge lesson, global efforts would hopefully lead to effective control of this pandemic.
- Open Access
- 1 January 2019
- Published by Medknow in Lung India
- Vol. 36 (4) , 285-287
Diaphragmatic dysfunction in chronic obstructive pulmonary disease
Lung India, Official publication of the Indian Chest Society
- 1 January 2019
- Published by Medknow in Lung India
- Vol. 36 (4) , 285-287
Open AccessDiaphragmatic dysfunction in chronic obstructive pulmonary disease
Lung India, Official publication of the Indian Chest Society
- Open Access
- 1 January 2018
- Published by Medknow in Lung India
- Vol. 35 (2) , 95-97
Pneumonia bugs and determinants of their occurrence
- 1 January 2018
- Published by Medknow in Lung India
- Vol. 35 (2) , 95-97
Open AccessPneumonia bugs and determinants of their occurrence
- Open Access
- 1 January 2018
- Published by Medknow in Lung India
- Vol. 35 (6) , 459-460
Respiratory disease burden in India: Indian chest society SWORD survey
- 1 January 2018
- Published by Medknow in Lung India
- Vol. 35 (6) , 459-460
Open AccessRespiratory disease burden in India: Indian chest society SWORD survey
- 15 March 2017
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 195 (6) , 801-813
Interstitial Lung Disease in India. Results of a Prospective Registry
Rationale: Interstitial lung disease (ILD) is a heterogeneous group of acute and chronic inflammatory and fibrotic lung diseases. Existing ILD registries have had variable findings. Little is known about the clinical profile of ILDs in India. Objectives: To characterize new-onset ILDs in India by creating a prospective ILD using multidisciplinary discussion (MDD) to validate diagnoses. Methods: Adult patients of Indian origin living in India with new-onset ILD (27 centers, 19 Indian cities, March 2012–June 2015) without malignancy or infection were included. All had connective tissue disease (CTD) serologies, spirometry, and high-resolution computed tomography chest. ILD pattern was defined by high-resolution computed tomography images. Three groups independently made diagnoses after review of clinical data including that from prompted case report forms: local site investigators, ILD experts at the National Data Coordinating Center (NDCC; Jaipur, India) with MDD, and experienced ILD experts at the Center for ILD (CILD; Seattle, WA) with MDD. Cohen’s κ was used to assess reliability of interobserver agreement. Measurements and Main Results: A total of 1,084 patients were recruited. Final diagnosis: hypersensitivity pneumonitis in 47.3% (n = 513; exposure, 48.1% air coolers), CTD-ILD in 13.9%, and idiopathic pulmonary fibrosis in 13.7%. Cohen’s κ: 0.351 site investigator/CILD, 0.519 site investigator/NDCC, and 0.618 NDCC/CILD. Conclusions: Hypersensitivity pneumonitis was the most common new-onset ILD in India, followed by CTD-ILD and idiopathic pulmonary fibrosis; diagnoses varied between site investigators and CILD experts, emphasizing the value of MDD in ILD diagnosis. Prompted case report forms including environmental exposures in prospective registries will likely provide further insight into the etiology and management of ILD worldwide.
- 15 March 2017
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 195 (6) , 801-813
Interstitial Lung Disease in India. Results of a Prospective Registry
Rationale: Interstitial lung disease (ILD) is a heterogeneous group of acute and chronic inflammatory and fibrotic lung diseases. Existing ILD registries have had variable findings. Little is known about the clinical profile of ILDs in India. Objectives: To characterize new-onset ILDs in India by creating a prospective ILD using multidisciplinary discussion (MDD) to validate diagnoses. Methods: Adult patients of Indian origin living in India with new-onset ILD (27 centers, 19 Indian cities, March 2012–June 2015) without malignancy or infection were included. All had connective tissue disease (CTD) serologies, spirometry, and high-resolution computed tomography chest. ILD pattern was defined by high-resolution computed tomography images. Three groups independently made diagnoses after review of clinical data including that from prompted case report forms: local site investigators, ILD experts at the National Data Coordinating Center (NDCC; Jaipur, India) with MDD, and experienced ILD experts at the Center for ILD (CILD; Seattle, WA) with MDD. Cohen’s κ was used to assess reliability of interobserver agreement. Measurements and Main Results: A total of 1,084 patients were recruited. Final diagnosis: hypersensitivity pneumonitis in 47.3% (n = 513; exposure, 48.1% air coolers), CTD-ILD in 13.9%, and idiopathic pulmonary fibrosis in 13.7%. Cohen’s κ: 0.351 site investigator/CILD, 0.519 site investigator/NDCC, and 0.618 NDCC/CILD. Conclusions: Hypersensitivity pneumonitis was the most common new-onset ILD in India, followed by CTD-ILD and idiopathic pulmonary fibrosis; diagnoses varied between site investigators and CILD experts, emphasizing the value of MDD in ILD diagnosis. Prompted case report forms including environmental exposures in prospective registries will likely provide further insight into the etiology and management of ILD worldwide.
- Open Access
- 1 March 2017
- Published by Wolters Kluwer Health in Lung India
- Vol. 34 (2) , 117-119
Nonsmoker COPD: Is it a reality?
Lung India, Official publication of the Indian Chest Society
- 1 March 2017
- Published by Wolters Kluwer Health in Lung India
- Vol. 34 (2) , 117-119
Open AccessNonsmoker COPD: Is it a reality?
Lung India, Official publication of the Indian Chest Society
- Open Access
- 1 January 2016
- Published by Medknow in Lung India
- Vol. 33 (2) , 125-8
Assessment of the mind in chronic obstructive pulmonary disease: Mind or never mind
Lung India, Official publication of the Indian Chest Society
- 1 January 2016
- Published by Medknow in Lung India
- Vol. 33 (2) , 125-8
Open AccessAssessment of the mind in chronic obstructive pulmonary disease: Mind or never mind
Lung India, Official publication of the Indian Chest Society
- Open Access
- 1 January 2015
- Published by Medknow in Lung India
- Vol. 32 (5) , 518-20
Miliary nodules on chest radiographs: A diagnostic dilemma
- 1 January 2015
- Published by Medknow in Lung India
- Vol. 32 (5) , 518-20
Open AccessMiliary nodules on chest radiographs: A diagnostic dilemma
- Open Access
- 1 January 2015
- Published by Medknow in Lung India
- Vol. 32 (4) , 421
Atlas of fiberoptic bronchoscopy
- 1 January 2015
- Published by Medknow in Lung India
- Vol. 32 (4) , 421
Open AccessAtlas of fiberoptic bronchoscopy
- Open Access
- 1 January 2014
- Published by Medknow in Lung India
- Vol. 31 (2) , 107-9
Unusual sojourn of not-so-unusual pathogens
Lung India, Official publication of the Indian Chest Society
- 1 January 2014
- Published by Medknow in Lung India
- Vol. 31 (2) , 107-9
Open AccessUnusual sojourn of not-so-unusual pathogens
Lung India, Official publication of the Indian Chest Society